MediciNova
MNOV

MediciNova (MNOV) analyst forecast and price target

Analyst forecast

Buy

Consensus of 3 analyst ratings

Buy
3
Hold
0
Sell
0

Recent analyst ratings

FirmActionRatingPrice targetDate
D. Boral CapitalMaintainedBuy$9.00May 4, 2026
Maxim GroupMaintainedBuy$6.00Mar 23, 2026
HC Wainwright & Co.Initiated CoverageBuy$10.00Mar 16, 2026
D. Boral CapitalMaintainedBuy$9.00Jan 30, 2026
D. Boral CapitalMaintainedBuy$9.00Dec 18, 2025
D. Boral CapitalMaintainedBuy$9.00Dec 8, 2025
D. Boral CapitalMaintainedBuy$9.00Nov 4, 2025
D. Boral CapitalMaintainedBuy$9.00Oct 31, 2025
D. Boral CapitalMaintainedBuy$9.00Sep 22, 2025
D. Boral CapitalMaintainedBuy$9.00Aug 27, 2025
D. Boral CapitalMaintainedBuy$9.00Jul 24, 2025
B. Riley SecuritiesMaintainedBuy$5.00 from $6.00Jun 16, 2025
D. Boral CapitalMaintainedBuy$9.00Apr 9, 2025
D. Boral CapitalMaintainedBuy$9.00Mar 14, 2025
D. Boral CapitalMaintainedBuy$9.00Feb 21, 2025
D. Boral CapitalMaintainedBuy$9.00Dec 6, 2024
D. Boral CapitalInitiated CoverageBuy$9.00Dec 2, 2024

Frequently asked questions

  • Is MNOV a buy, sell, or hold?

    Analysts covering MediciNova currently average a Buy rating: 3 buy, 0 hold and 0 sell, from 3 analysts. Ratings reflect analyst opinion, not investment advice.

  • What is the latest analyst rating on MNOV?

    On May 4, 2026, D. Boral Capital maintained MediciNova at Buy with a price target of $9.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.